Haleon demonstrated solid revenue growth and improved profitability, although some expenses have increased
Filed as: Financial Results for the Year Ended 31 December 2025
Summary
Haleon demonstrated solid revenue growth and improved profitability, although some expenses have increased.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | 43106420000 | 37205893000 | +15.9% |
| Gross Profit | 16852330000 | 12818527000 | +31.5% |
| Profit After Tax | 6373151000 | 4578247000 | +39.2% |
| Total Assets | 27160875000 | 21800563000 | +24.6% |
| Total Equity | 14797043000 | 11988169000 | +23.4% |
| Cash Generated from Operations | 10359909000 | 8517127000 | +21.6% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue rose to Rs 43.11 billion from Rs 37.21 billion, up 15.5%
- Gross profit increased to Rs 16.85 billion from Rs 12.82 billion, reflecting a stronger margin.
- Profit after tax improved to Rs 6.37 billion from Rs 4.58 billion, marking a growth of 39.1%.
Haleon Pakistan Limited (HALEON) on Nafa
Last price Rs 692.00 · Pharmaceuticals · You can own HALEON shares from your phone.
More HALEON announcements
- NoticeChange of Name of External Auditors
- NoticeTransmission of Quarterly Report for the Period Ended 30 September 2026
- Material informationHaleon Begins Inhouse Production of PanadolHaleon Pakistan starts manufacturing Panadol 500mg at Jamshoro facility, enhancing production capacity.
- Financial resultHaleon Pakistan Limited reported a stable performance for the nine months ended September 30, 2026Filed as: Financial Results for the Quarter Ended 30 September 2026
- NoticeNotice of Board of Directors Meeting - (Q3-2026)
- NoticeCredit of Interim Cash Dividend
Source: Haleon Pakistan Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.